Patterns of gene expression are widely utilized to identify various diseases. Biomarkers are used in diagnosis of various diseases such as infectious diseases, cancer, autoimmune diseases, and others. The increase in prevalence of various diseases is rising the demand for biomarker technologies.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Consumables, Instruments, Services, Software/Informatics), Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay), Test Type (Liquid Biopsy, Solid Biopsy), Research Area (Genomics, Proteomics, Metabolomics, Other Research Areas), Application (Biomarker Identification, Validation and Development Research, Routine Biomarker-based Tests) – Industry Trends and Forecast to 2031.
.
The Global Biomarker Technologies Market size was valued at USD 42.03 USD Billion in 2023.
The Global Biomarker Technologies Market is projected to grow at a CAGR of 14.25% during the forecast period of 2024 to 2031.
The major players operating in the market include , Enzo Biochem , Bio,Rad Laboratories , Merck KGaA , PerkinElmer , QIAGEN , Agilent Technologies , Bruker , Epigenomics AG , MESO SCALE DIAGNOSTICS LLC , EKF Diagnostics Holdings plc , General Electric Company , Nexus,Dx , LifeSign LLC , F. Hoffmann,La Roche Ltd and others ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
